SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-008512
Filing Date
2022-05-09
Accepted
2022-05-09 16:21:40
Documents
53
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q oric-20220331.htm   iXBRL 10-Q 2304668
2 EX-10.2 oric-ex10_2.htm EX-10.2 518020
3 EX-10.3 oric-ex10_3.htm EX-10.3 746918
4 EX-31.1 oric-ex31_1.htm EX-31.1 20687
5 EX-31.2 oric-ex31_2.htm EX-31.2 20673
6 EX-32.1 oric-ex32_1.htm EX-32.1 11652
7 EX-32.2 oric-ex32_2.htm EX-32.2 11638
  Complete submission text file 0000950170-22-008512.txt   8326251

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT oric-20220331_def.xml EX-101.DEF 134843
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT oric-20220331_cal.xml EX-101.CAL 29826
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT oric-20220331.xsd EX-101.SCH 35136
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT oric-20220331_pre.xml EX-101.PRE 244190
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT oric-20220331_lab.xml EX-101.LAB 347060
47 EXTRACTED XBRL INSTANCE DOCUMENT oric-20220331_htm.xml XML 1196154
Mailing Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 388-5600
Oric Pharmaceuticals, Inc. (Filer) CIK: 0001796280 (see all company filings)

IRS No.: 471787157 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39269 | Film No.: 22905352
SIC: 2834 Pharmaceutical Preparations